Cancer clinical trials in the region Bourgogne-Franche-Comté
210 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Phase 2
Lung cancer
#NCT05676931
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
Hôpital Foch (Suresnes), Hôpital de la Croix Rousse - Hospices Civils de Lyon (Lyon)
Arcus Biosciences
Phase 2
Lymphoma
#NCT04984837
T cell lymphoma
Peripheral T cell lymphoma
None
> 60 ml/min
50-60 ml/min
30-50 ml/min
1
2
Systemic Treatment-Naive
Allogeneic stem cell transplant
CHU Amiens-Picardie (site sud) (Amiens), Hôpital Claude Huriez (Lille), Hôpital Necker Enfants malades - AP-HP (Paris ), Centre Hospitalier de Perpignan (Perpignan), Centre Henri Becquerel (Rouen ) (and 38 more...)
Organisation de recherche universitaire sur le lymphome
Phase 2
Lymphoma
#NCT04104776
B cell lymphoma
Large B cell lymphoma
None
Treated / Controled
2
3 or more
Systemic Treatment-Naive
Allogeneic stem cell transplant
Centre Léon Bérard (Lyon), Institut Bergonié (Bordeaux), Centre Oscar Lambret (Lille), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Nantes (Nantes) (and 2 more...)
Constellation Pharmaceutique
Phase 2
Lymphoma
#NCT04104776
T cell lymphoma
Peripheral T cell lymphoma
None
Treated / Controled
1
2
3 or more
Systemic Treatment-Naive
Allogeneic stem cell transplant
Centre Léon Bérard (Lyon), Institut Bergonié (Bordeaux), Centre Oscar Lambret (Lille), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), Centre Hospitalier Universitaire de Nantes (Nantes) (and 2 more...)
Constellation Pharmaceutique
Phase 2
Breast cancer
#NCT04104776
Locally Advanced
Metastatic
Other mutation
Systemic Treatment-Naive
Institut Bergonié (Bordeaux), Centre Oscar Lambret (Lille), Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire - Site Hôtel Dieu (Nantes), ICANS - Institut de cancérologie Strasbourg Europe (Strasbourg) (and 2 more...)
Constellation Pharmaceutique
Phase 2
Lymphoma
#NCT05751798
None
Treated / Controled
> 60 ml/min
50-60 ml/min
30-50 ml/min
1
2
3 or more
Systemic Treatment-Naive
Immunotherapy
Centre Léon Bérard (Lyon)
OSE Immunotherapeutics
Phase 2
Colon cancer
Rectal cancer
Anal cancer
#NCT04954820
Neuroendocrine tumor
Systemic Treatment-Naive
Systemic Treatment-Naive
Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ), Centre Jean Perrin (Clermont Ferrand ), Institut du cancer de Montpellier (Montpellier), Institut Bergonié (Bordeaux), Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest) (and 22 more...)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2
Breast cancer
Lung cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05751798
MSI/dMMR
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
Systemic Treatment-Naive
Immunotherapy
Systemic Treatment-Naive
Immunotherapy
Centre Léon Bérard (Lyon)
OSE Immunotherapeutics
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
#NCT05384626
Locally Advanced
Metastatic
Metastatic Castration-resistant
Other mutation
BRAF
MET
HER2
RET
NTRK-1/2/3
KRAS G12C
KRAS non G12C
BRCA 1/2
AKT
PIK3CA
PALB2
ESR
FGFR
PTEN
MSI/dMMR
ATM
CDK12
HOXB13
CHEK 1/2
NRAS
Systemic Treatment-Naive
Gustave Roussy (Villejuif), IUCT Oncopôle (Toulouse), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Nuvalent Inc.
Phase 2
Lung cancer
#NCT05384626
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
ALK
Immunotherapy
Chemotherapy
Targeted therapy
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Gustave Roussy (Villejuif), Centre Léon Bérard (Lyon), Institut de Cancérologie de l'Ouest - Site de Saint-Herblain (Saint-Herblain)
Nuvalent Inc.